BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30290019)

  • 1. Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study.
    Dong XQ; Wu Z; Li J; Wang GQ; Zhao H;
    J Gastroenterol Hepatol; 2019 Apr; 34(4):755-763. PubMed ID: 30290019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir.
    Kong Y; Sun Y; Zhou J; Wu X; Chen Y; Piao H; Lu L; Ding H; Nan Y; Jiang W; Xu Y; Xie W; Li H; Feng B; Shi G; Chen G; Li H; Zheng H; Cheng J; Wang T; Liu H; Lv F; Shao C; Mao Y; Sun J; Chen T; Han T; Han Y; Wang L; Ou X; Zhang H; Jia J; You H
    J Viral Hepat; 2019 May; 26(5):576-585. PubMed ID: 30624000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chu SH; Chan FK; Sung JJ; Chan HL
    Antivir Ther; 2011; 16(2):165-72. PubMed ID: 21447865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study.
    Liang X; Xie Q; Tan D; Ning Q; Niu J; Bai X; Chen S; Cheng J; Yu Y; Wang H; Xu M; Shi G; Wan M; Chen X; Tang H; Sheng J; Dou X; Shi J; Ren H; Wang M; Zhang H; Gao Z; Chen C; Ma H; Chen Y; Fan R; Sun J; Jia J; Hou J
    J Viral Hepat; 2018 Mar; 25(3):296-305. PubMed ID: 29080299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal monitoring of liver fibrosis status by transient elastography in chronic hepatitis B patients during long-term entecavir treatment.
    Wu SD; Liu LL; Cheng JL; Liu Y; Cheng LS; Wang SQ; Ma W; Chen LP; Tseng YJ; Wang JY; Shen XZ; Jiang W
    Clin Exp Med; 2018 Aug; 18(3):433-443. PubMed ID: 29696462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
    Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
    Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B.
    Goyal R; Mallick SR; Mahanta M; Kedia S; Shalimar ; Dhingra R; Sharma H; Das P; Datta Gupta S; Panda S; Acharya SK
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1738-45. PubMed ID: 23808910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].
    Chen GF; Ping J; Gu HT; Zhao ZM; Zhou Y; Xing F; Tao YY; Mu YP; Liu P; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):145-150. PubMed ID: 28297803
    [No Abstract]   [Full Text] [Related]  

  • 9. How intrahepatic cholestasis affects liver stiffness in patients with chronic hepatitis B: a study of 1197 patients with liver biopsy.
    Guo H; Liao M; Jin J; Zeng J; Li S; Schroeder DR; Zheng J; Zheng R; Chen S
    Eur Radiol; 2020 Feb; 30(2):1096-1104. PubMed ID: 31673836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.
    Rinaldi L; Ascione A; Messina V; Rosato V; Valente G; Sangiovanni V; Zampino R; Marrone A; Fontanella L; de Rosa N; Orabona P; Buonomo C; Chirianni A; Adinolfi LE; Piai G
    Infection; 2018 Apr; 46(2):231-238. PubMed ID: 29335905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B.
    Ji D; Chen Y; Shang Q; Liu H; Tan L; Wang J; Chen Y; Li Q; Long Q; Song L; Jiang L; Xiao G; Yu Z; Chen L; Hu X; Wang X; Chen D; Li Z; Dong Z; Chen G; Yang Y
    Am J Gastroenterol; 2021 Aug; 116(8):1676-1685. PubMed ID: 33840727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance between liver biopsy and Fibroscan® in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation.
    Kim SU; Kim JK; Park YN; Han KH
    PLoS One; 2012; 7(2):e32233. PubMed ID: 22384189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Chon YE; Park JY; Myoung SM; Jung KS; Kim BK; Kim SU; Kim DY; Ahn SH; Han KH
    Am J Gastroenterol; 2017 Jun; 112(6):882-891. PubMed ID: 28374814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.
    Wang JL; Du XF; Chen SL; Yu YQ; Wang J; Hu XQ; Shao LY; Chen JZ; Weng XH; Zhang WH
    World J Gastroenterol; 2015 Aug; 21(32):9598-606. PubMed ID: 26327767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.
    Chan HL; Wong GL; Choi PC; Chan AW; Chim AM; Yiu KK; Chan FK; Sung JJ; Wong VW
    J Viral Hepat; 2009 Jan; 16(1):36-44. PubMed ID: 18673426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B.
    Lim SG; Cho SW; Lee YC; Jeon SJ; Lee MH; Cho YJ; Kim SS; Kim YB; Seok JY; Cheong JY; Kim JH
    Hepatogastroenterology; 2011; 58(106):539-45. PubMed ID: 21661428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B Patients.
    Fan R; Li G; Yu N; Chang X; Arshad T; Liu WY; Chen Y; Wong GL; Jiang Y; Liang X; Chen Y; Jin XZ; Dong Z; Leung HH; Wang XD; Zeng Z; Yip TC; Xie Q; Tan D; You S; Ji D; Zhao J; Sanyal AJ; Sun J; Zheng MH; Wong VW; Yang Y; Hou J
    Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3070-3079.e13. PubMed ID: 36933605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir.
    Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
    Liver Int; 2014 Sep; 34(8):1216-23. PubMed ID: 24267737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy.
    Kuo YH; Lu SN; Chen CH; Chang KC; Hung CH; Tai WC; Tsai MC; Tseng PL; Hu TH; Wang JH
    PLoS One; 2014; 9(3):e93160. PubMed ID: 24682088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.